Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharmascience, a Quebec-based genetic pharmaceutical firm, has taken over a developer of targeted therapeutics, primarily in oncology, Aegera Therapeutics.
Subscribe to our email newsletter
Following the acquisition, Aegera’s 20 plus employees will be joining Pharmascience’s team.
The acquisition will allow Pharmascience to enhance its research and development activities through the continuance of Aegera’s programs.
Pharmascience president and COO Mario Deschamps said they are pleased to welcome Aegera’s employees to their team, which will broaden and strengthen the development of their organization.